BDBM432118 (S)-2-(5-(2-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydroisoquinolin-6- yl)-4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethylpyridin-3-yl)-2- (tert-butoxy)acetic acid::US10577353, Compound 13

SMILES Cc1nc(C)c(-c2ccc3CN(CCc3c2)c2nc3ccccc3s2)c(N2CCC(C)(C)CC2)c1[C@H](OC(C)(C)C)C(O)=O

InChI Key InChIKey=VNVOQCJFSJFNQQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 432118   

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (No. 5)

US Patent
LigandPNGBDBM432118(US10577353, Compound 13 | (S)-2-(5-(2-(benzo[d]thi...)
Affinity DataEC50:  7nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent